Turning Momentum into Scale

At bm|t, we con­tinue to believe that resilience is not a pas­sive qual­ity, but an active dis­ci­pline. In a mar­ket envi­ron­ment that still demands focus, real­ism and cap­i­tal effi­ciency, the sec­ond quar­ter of 2026 showed once again that strong teams with clear mis­sions can con­tinue to build, attract sup­port and cre­ate momentum.

Build­ing on ear­lier reflec­tions around bold­ness and dri­ving change, this quar­ter high­lighted another impor­tant dimen­sion of entre­pre­neur­ial progress: the abil­ity to trans­late momen­tum into scale. For inno­v­a­tive com­pa­nies, this requires not only tech­no­log­i­cal excel­lence, but also tim­ing, trusted part­ner­ships and the will­ing­ness to keep mov­ing for­ward in dynamic mar­ket conditions.

Across Thürin­gen and beyond, bm|t remains com­mit­ted to sup­port­ing founders and man­age­ment teams who com­bine ambi­tion with dis­ci­plined exe­cu­tion. That com­mit­ment con­tin­ues to be reflected in the devel­op­ment of the port­fo­lio, the breadth of the financ­ing plat­form and the grow­ing vis­i­bil­ity of the regional inno­va­tion ecosystem.

Your bm|t Team

Portfolio Developments

The sec­ond quar­ter brought encour­ag­ing sig­nals from the bm|t port­fo­lio. Pos­i­tive financ­ing activ­ity, strate­gic ecosys­tem vis­i­bil­ity and con­tin­ued oper­a­tional progress across investee part­ners all rein­forced the qual­ity and resilience that remain cen­tral to sus­tain­able com­pany building.

A par­tic­u­larly encour­ag­ing devel­op­ment came from Smart­Dye­Liv­ery, which secured financ­ing in the mil­lions to sup­port its next phase of growth. The com­pany is advanc­ing a plat­form around phar­ma­ceu­ti­cal active ingre­di­ents and its fur­ther devel­op­ment is being sup­ported by fresh cap­i­tal and an expanded share­holder base, under­lin­ing con­fi­dence in the company’s tech­nol­ogy and mar­ket potential.

Another pos­i­tive sig­nal came from neu­ro­care, one of bm|t’s investee part­ners in the neu­rother­apy and men­tal health space. neurocare’s posi­tion­ing around per­son­al­ized dig­i­tal ther­a­pies and non-inva­sive neu­rotech­nol­ogy con­tin­ues to reflect the type of scal­able, high-impact health­care inno­va­tion that remains highly rel­e­vant within the broader life sci­ences and dig­i­tal health landscape.

As ref­er­enced for this quar­ter, neu­ro­care also received EUR 2 mil­lion in financ­ing. This pro­vides a fur­ther pos­i­tive marker for the company’s devel­op­ment and sup­ports the view that dif­fer­en­ti­ated men­tal health and neu­rotech­nol­ogy plat­forms con­tinue to attract back­ing when sup­ported by a clear propo­si­tion and strong execution.

Innovation Ecosystem

A fur­ther high­light of the quar­ter was the Investor Days Thürin­gen on 11 June 2026. The event was posi­tioned as a plat­form to dis­cover inno­va­tions, cre­ate col­lab­o­ra­tions and gen­er­ate deal flow, bring­ing together star­tups, investors and inno­va­tion stake­hold­ers in Thüringen.

For bm|t, for­mats like Investor Days Thürin­gen mat­ter because they do more than show­case indi­vid­ual com­pa­nies. They strengthen con­nec­tiv­ity across the regional ecosys­tem, cre­ate direct access to founders and tech­nolo­gies, and help trans­late local inno­va­tion strength into broader financ­ing, coop­er­a­tion and mar­ket opportunities.

The con­tin­ued rel­e­vance of such plat­forms is closely aligned with bm|t’s man­date. Sus­tain­able inno­va­tion ecosys­tems are built not only through cap­i­tal, but through repeated inter­ac­tion between entre­pre­neurs, investors, insti­tu­tions and indus­trial part­ners. This is exactly where high-qual­ity regional events can cre­ate dis­pro­por­tion­ate value over time.

Strong Platform, Clear Mission

With a broad invest­ment plat­form span­ning mul­ti­ple funds and financ­ing for­mats, bm|t is posi­tioned to sup­port inno­v­a­tive and growth-ori­ented com­pa­nies through­out dif­fer­ent stages of devel­op­ment. This ranges from early-stage tech­nol­ogy ven­tures to later-stage and estab­lished busi­nesses pur­su­ing growth, trans­for­ma­tion or suc­ces­sion solutions.

In par­tic­u­lar, bm|t was pre­vi­ously not as well-posi­tioned to pro­vide growth financ­ing to larger, already estab­lished Thuringian small and medium-sized enter­prises. This changed with the launch of the Mit­tel­stands-Fonds Thürin­gen II (MFT II) in 2025.

This mat­ters strate­gi­cally because Thüringen’s inno­va­tion strength does not end with start-ups. By com­bin­ing early-stage, growth-stage and later-stage capa­bil­i­ties, includ­ing MFT II, bm|t can remain a reli­able equity part­ner not only for young tech­nol­ogy com­pa­nies and scale-ups, but also for estab­lished medium-sized busi­nesses and the region’s hid­den champions.

Outlook

Look­ing ahead to the sec­ond half of 2026, the mar­ket envi­ron­ment is likely to remain selec­tive, but con­struc­tive for com­pa­nies with strong posi­tion­ing, cred­i­ble mile­stones and dis­ci­plined growth paths. In that con­text, Thürin­gen-linked inno­va­tors across deep tech, health­care, indus­trial tech­nolo­gies and other high-value niches con­tinue to hold attrac­tive oppor­tu­ni­ties for investors and strate­gic partners.

Together with trusted co-investors and ecosys­tem part­ners, bm|t will con­tinue to sup­port port­fo­lio com­pa­nies through new invest­ments, fol­low-on financ­ing and strate­gic guid­ance. The com­bi­na­tion of entre­pre­neur­ial resilience, ecosys­tem con­nec­tiv­ity and a broad fund fam­ily [SB1] will remain an impor­tant foun­da­tion for strength­en­ing Thüringen’s inno­va­tion econ­omy in 2026 and beyond.